A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors

Clinical trial NCT05086822 · COMPLETED

Trial details

NCT number: NCT05086822
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2014-09-09
Primary completion: 2017-08-28
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.